Literature DB >> 11805615

Summary statement: the Sygen(GM-1 ganglioside) clinical trial in acute spinal cord injury.

M G Fehlings, M B Bracken.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11805615     DOI： 10.1097/00007632-200112151-00016

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN： 0362-2436            Impact factor:   3.468


× No keyword cloud information.
  4 in total

1.  Methylprednisolone in acute spinal cord injuries.

Authors:  P A O'Connor; O McCormack; C Gavin; R Dungan; C Kirke; D McCormack; J O'Byrne; M Stephens; F McManus; M Walsh
Journal:  Ir J Med Sci       Date:  2003 Jan-Mar       Impact factor: 1.568

Review 2.  A Review on the Etiology and Management of Pediatric Traumatic Spinal Cord Injuries.

Authors:  Amira Benmelouka; Laila Salah Shamseldin; Anas Zakarya Nourelden; Ahmed Negida
Journal:  Adv J Emerg Med       Date:  2019-10-10

Review 3.  Turning the spotlight on the oligosaccharide chain of GM1 ganglioside.

Authors:  Elena Chiricozzi; Erika Di Biase; Giulia Lunghi; Maria Fazzari; Nicoletta Loberto; Massimo Aureli; Laura Mauri; Sandro Sonnino
Journal:  Glycoconj J       Date:  2021-02-23       Impact factor: 2.916

4.  Efficacy and safety of 9 nonoperative regimens for the treatment of spinal cord injury: A network meta-analysis.

Authors:  Da-Nian Ma; Xia-Qi Zhang; Jie Ying; Zhong-Jun Chen; Li-Xin Li
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.